Table 1.
Patient overview
| Characteristic | LeFort III | Monobloc | Monobloc with LeFort II | Combined | p |
|---|---|---|---|---|---|
| Patients, n (%) | 24 (100) | 18 (100) | 3 (100) | 45 (100) | 0.934* |
| Female, n (%) | 14 (58.3) | 10 (55.6) | 2 (66.7) | 26 (57.8) | |
| Male, n (%) | 10 (41.4) | 8 (44.4) | 1 (33.3) | 19 (42.2) | |
| Patients | 0.242* | ||||
| White, n (%) | 19 (79.2) | 15 (83.3) | 1 (33.3) | 35 (77.8) | |
| Black, n (%) | 4 (16.7) | 1 (5.6) | 1 (33.3) | 6 (13.3) | |
| Other, n (%) | 1 (4.2) | 2 (11.1) | 1 (33.3) | 4 (8.9) | |
| Syndrome | 0.074* | ||||
| Apert, n (%) | 6 (25.0) | 5 (27.8) | 3 (100) | 14 (31.1) | |
| Crouzon, n (%) | 12 (50.0) | 6 (33.3) | 0 (0) | 18 (40.0) | |
| Pfeiffer, n (%) | 6 (25.0) | 7 (38.9) | 0 (0) | 13 (28.9) | |
| Age at surgery, years | 5.9 (5.2–6.5) | 6.6 (5.6–8.8) | 6.5 (5.6–6.8) | 6.1 (5.5–7.5) | 0.009** |
| Age at imaging | |||||
| Preoperative imaging age, months | 4.1 (1.2–6.2) | 2.3 (1.0–4.6) | 1.3 (1.0–1.4) | 2.5 (1.1–5.0) | 0.235** |
| Early (< 1 year) postoperative imaging, months | 4.5 (3.7–5.7) | 4.8 (4.6–5.3) | 3.7 (3.5–4.7) | 4.6 (3.9–5.7) | 0.400** |
| Late (≥ 1 year) Postoperative imaging, years | 6.7 (4.1–9.0) | 8.6 (5.6–10.5) | 0 | 7.1 (4.5–9.5) | 0.364** |
*p-values are from chi squared analysis, p < 0.05 is considered statistically significant
**p-values are from Kruskal–Wallis test for non-parametric data, p < 0.05 is considered statistically significant